- The Wall Street Journal•8 days ago
A minimally invasive procedure to repair diseased heart valves delivered about the same health outcomes for patients as open-heart surgery, a result doctors say could widen use of the new procedure.
- Investor's Business Daily•8 days ago
Edwards and Boston stocks got a boost Friday after Medtronic published a study showing a new method of inserting a heart-valve isn't inferior to open-heart surgery.
- Reuters•8 days ago
Medtronic's TAVR systems succeeded in demonstrating non-inferiority with no statistically significant difference in a combination of all-cause mortality and disabling stroke. The rate was 12.6 percent for TAVR and 14 percent for surgical valve replacement.
EW : Summary for Edwards Lifesciences Corporatio - Yahoo Finance
Edwards Lifesciences Corporation (EW)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Bid||89.22 x 100|
|Ask||95.75 x 100|
|Day's Range||94.26 - 96.03|
|52 Week Range||81.12 - 121.75|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||36.62|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|